Inventiva (IVA) Convertible Debt (2022 - 2025)

Inventiva (IVA) posted quarterly Convertible Debt of $1.0 million for Q2 2025, down 39.77% year-over-year from $1.7 million in Q2 2024, and down 46.43% quarter-over-quarter from $1.9 million in Q4 2024.

Inventiva (IVA) Convertible Debt (2022 - 2025) Analysis & Trends

Inventiva's Convertible Debt history runs 4 years deep, the most recent figure standing at $1.0 million for Q2 2025.

  • In Q2 2025, Convertible Debt fell 39.77% year-over-year to $1.0 million; the TTM figure through Jun 2025 stood at $1.0 million (down 39.77% YoY), while the FY2024 annual figure was $1.9 million, up 12.25% from the prior year.
  • Convertible Debt for Q2 2025 stood at $1.0 million, down from $1.9 million in the prior quarter.
  • The five-year high for Convertible Debt was $1.9 million in Q4 2024, with the low at $1.0 million in Q2 2025.
  • The 4-year median for Convertible Debt is $1.6 million (2023), against an average of $1.5 million.
  • The sharpest annual moves came in 2023 and 2025: Convertible Debt surged 33.23% in 2023, then slumped 39.77% in 2025.
  • Inventiva's Convertible Debt stood at $1.3 million in 2022, then soared by 33.23% to $1.7 million in 2023, then grew by 12.25% to $1.9 million in 2024, then sank by 46.43% to $1.0 million in 2025.
  • Business Quant data shows IVA's Convertible Debt at $1.0 million in Q2 2025, $1.9 million in Q4 2024, and $1.7 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Inventiva 888.89 Mn 888.89 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.01 Mn
Dec 31, 2024 1.88 Mn
Jun 30, 2024 1.67 Mn
Dec 31, 2023 1.68 Mn
Jun 30, 2023 1.48 Mn
Dec 31, 2022 1.26 Mn